Yes, hepatitis B vaccine and Shingrix can be administered together
Based on established vaccine principles and FDA-approved data for Shingrix, you can safely co-administer hepatitis B vaccine and Shingrix (recombinant zoster vaccine) at the same visit, using separate anatomic sites (e.g., different arms).
Evidence Supporting Co-Administration
The FDA label for Shingrix demonstrates that this vaccine has been studied with multiple other adult vaccines administered concomitantly, including influenza, pneumococcal (both PPSV23 and PCV13), Tdap, and COVID-19 vaccines 1. In all these studies, there was no evidence of interference in immune response to either Shingrix or the co-administered vaccine (with one minor exception for pertactin in Tdap that is not clinically significant).
While hepatitis B vaccine was not specifically studied in the Shingrix clinical trials, the general principle of vaccine co-administration is well-established. Historical hepatitis B vaccine data confirms that when hepatitis B vaccine has been administered at the same time as other vaccines, no interference with the antibody response of the other vaccines has been demonstrated 2.
Practical Administration Guidelines
- Administer at separate anatomic sites: Give each vaccine in a different limb (e.g., one in each arm)
- Use separate syringes and needles for each vaccine
- Document both vaccines with site of administration
- Complete the full series: Hepatitis B requires 2-3 doses depending on formulation 3, and Shingrix requires 2 doses given 2-6 months apart 1
Expected Reactogenicity
Be aware that both vaccines can cause local and systemic reactions:
- Shingrix is notably reactogenic, with myalgia (38-64%), injection site pain, and fatigue being common 4
- When Shingrix was co-administered with other vaccines, the overall incidence of adverse events was similar to sequential administration 4
- Hepatitis B vaccine typically causes mild pain at injection site and low-grade fever in a minority of recipients 3
Counsel patients that they may experience more pronounced local reactions at both injection sites and systemic symptoms like myalgia and fatigue, but this does not indicate reduced efficacy.
Special Populations
For immunocompromised patients, both vaccines can be administered together:
- Shingrix is non-replicating and safe in immunocompromised individuals 5, 6
- Hepatitis B vaccine may require higher doses or additional doses in immunocompromised persons 3, 7
- Consider checking anti-HBs levels 1-2 months after completing the hepatitis B series in immunocompromised patients 3
Common Pitfall to Avoid
Do not delay either vaccine unnecessarily. The strategy of co-administration improves overall vaccine coverage 4. If a patient is due for both vaccines, administer them at the same visit rather than scheduling separate appointments, which increases the risk of incomplete vaccination series.